Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease
The FEBS Journal · 2023-06 · 290 (11) · 2805-2832
DOI: 10.1111/febs.16437 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 31.03.2022. Verfasst von Yizhuo Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience (IMB), The University of Queensland, St. Lucia, Australia. Hauptthemen laut MEDLINE: Histone Deacetylases, Neoplasms. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, University of Queensland.
Abstract (Originalsprache)
Histone deacetylases (HDACs) catalyse removal of acetyl groups from lysine residues on both histone and non‐histone proteins to control numerous cellular processes. Of the 11 zinc‐dependent classical HDACs, HDAC4, 5, 7 and 9 are class IIa HDAC enzymes that regulate cellular and developmental processes through both enzymatic and non‐enzymatic mechanisms. Over the last two decades, HDAC7 has been associated with key roles in numerous physiological and pathological processes. Molecular, cellular, in vivo and disease association studies have revealed that HDAC7 acts through multiple mechanisms to control biological processes in immune cells, osteoclasts, muscle, the endothelium and epithelium. This HDAC protein regulates gene expression, cell proliferation, cell differentiation and cell survival and consequently controls development, angiogenesis, immune functions, inflammation and metabolism. This review focuses on the cell biology of HDAC7, including the regulation of its cellular localisation and molecular mechanisms of action, as well as its associative and causal links with cancer and inflammatory, metabolic and fibrotic diseases. We also review the development status of small molecule inhibitors targeting HDAC7 and their potential for intervention in different disease contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Bioscience (IMB), The University of Queensland, St. Lucia, Australia.
- IMB Centre for Inflammation and Disease Research, The University of Queensland, St. Lucia, Australia.
- Australian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Australia.
ORCID-Profile: Matthew J Sweet
Förderung
- National Health and Medical Research Council
- University of Queensland
Zitieren
APA
Wang, Y., Abrol, R., Mak, J. Y. W., Das Gupta, K., Ramnath, D., Karunakaran, D., Fairlie, D. P., & Sweet, M. J. (2023). Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease. The FEBS Journal, 290(11), 2805-2832. https://doi.org/10.1111/febs.16437
Vancouver
Wang Y, Abrol R, Mak JYW, Das Gupta K, Ramnath D, Karunakaran D, et al. Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease. The FEBS Journal. 2023;290(11):2805-2832. doi:10.1111/febs.16437
BibTeX
@article{Wang2023,
author = {Wang, Yizhuo and Abrol, Rishika and Mak, Jeffrey Y W and Das Gupta, Kaustav and Ramnath, Divya and Karunakaran, Denuja and Fairlie, David P and Sweet, Matthew J},
title = {Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease},
journal = {The FEBS Journal},
year = {2023},
volume = {290},
number = {11},
pages = {2805--2832},
doi = {10.1111/febs.16437}
}
EUVIMED